Endoscopic hemostasis system cleared by FDA for nonvariceal upper GI bleeding

The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility and management of upper gastrointestinal bleeding not linked to varices, according to a company press release.“We are very excited to bring the innovative Nexpowder system to gastroenterologists,” Gio Di Napoli, president of gastrointestinal business at Medtronic, said in the release. “We considered the potential impact on physicians and patients alike by meeting a clear need to reduce mortality from upper GI bleeding, a condition that causes death for oneRead More

Related Articles